The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.
scientific article published on 8 May 2013
Author/s
author: Christian Thiede, Gerhard Ehninger, Martin Bornhäuser, Uwe Platzbecker, Johannes Schetelig, Christoph Röllig, Markus Schaich, Study Alliance Leukemia (SAL), Nona Shayegi, Caroline Heiderich
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.